BackgroundBeta-1,3-N-acetylglucosaminyltransferase involved in the synthesis of poly-N-acetyllactosamine. Catalyzes the initiation and elongation of poly-N-acetyllactosamine chains. Shows a marked preference for Gal(beta1-4)Glc(NAc)-based acceptors (PubMed:9892646). Probably constitutes the main polylactosamine synthase.
DescriptionB3GNT2 Polyclonal Antibody. Unconjugated. Raised in: Rabbit.
Formulation0.03% Proclin 300, 50% Glycerol, 0.01M PBS, PH 7.4.
SpecificityHuman
IsotypeIgG
Uniprot IDQ9NY97
PurificationProtein G purified
ImmunogenRecombinant Human N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 protein (29-397AA)
StorageShipped at 4°C. Upon delivery aliquot and store at -20°C (short-term) or -80°C (long-term). Avoid repeated freeze.
Alternative NamesN-acetyllactosaminide beta-1, 3-N-acetylglucosaminyltransferase 2 (EC:2.4.1.1493 Publications, B3GNT2, B3GALT7, B3GNT1, Beta-1, 3-N-acetylglucosaminyltransferase 1, BGnT-1, Beta-1, 3-Gn-T1, Beta3Gn-T1, Beta-1, 3-galactosyltransferase 7, Beta-1, 3-GalTase 7, Beta3Gal-T7, Beta3GalT7, b3Gal-T7, Beta-3-Gx-T7, UDP-Gal:beta-GlcNAc beta-1, 3-galactosyltransferase 7, UDP-GlcNAc:betaGal beta-1, 3-N-acetylglucosaminyltransferase 2, BGnT-2, Beta-1, 3-Gn-T2, Beta-1, 3-N-acetylglucosaminyltransferase 2, Beta3Gn-T2, UDP-galactose:beta-N-acetylglucosamine beta-1, 3-galactosyltransferase 7
ApplicationELISA, WB, IHC; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200